Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumours without myasthenia gravis: a prospective, single-arm clinical trial
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf122 ↗Kurz gefasst
Klinische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Yuan-Liang Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Thymectomy, Thymus Neoplasms, Patient Discharge, Thoracoscopy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives Subxiphoid thoracoscopic surgery is an effective method for treating thymic tumours. We performed the first evaluation of the safety and feasibility of same-day discharge (SDD) in patients undergoing this procedure and summarized their associated clinical experience. METHODS We conducted a single-arm, single-centre prospective clinical trial. This study was registered at www.chictr.org.cn (ChiCTR2300077148). The subjects were patients with a preoperative clinical diagnosis of thymic tumour. All eligible patients underwent examinations and preparations at the preoperative preparation centre and subsequently underwent a subxiphoid thoracoscopic thymectomy. The evaluation indicators included R0 (complete resection without residual tumour) resection rate, SDD completion rate, 30-day postoperative readmission rate, number of emergency visits, perioperative complication rate, length of stay and total medical costs. RESULTS A total of 39 patients were enrolled between November 2023 and April 2024. All patients underwent subxiphoid thoracoscopic resection of the thymic tumours to achieve R0 resection. The completion rate of the SDD surgery was 92.3% (36/39). The perioperative complication rate was 5.6% (2/36 patients). Only 2.8% (1/36) of the patients were readmitted within 1 month of an emergency visit due to pneumothorax. The median length of stay was 11 h (interquartile range 10–14), and the median total medical cost was 19 400 renminbi (interquartile range 18 500–21 100). CONCLUSIONS The SDD procedure may be safe and feasible for selected patients undergoing subxiphoid thoracoscopic thymectomy, based on a small sample size. Large-scale studies are needed to confirm these preliminary findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.
- Department of Gastroenterology, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.
- Department of Pathology, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.
Zitieren
APA
Zheng, Y. L., Yuan, Y. P., Liang, X. Y., & Liao, H. L. (2025). Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumours without myasthenia gravis: a prospective, single-arm clinical trial. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf122
Vancouver
Zheng YL, Yuan YP, Liang XY, Liao HL. Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumours without myasthenia gravis: a prospective, single-arm clinical trial. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf122
BibTeX
@article{Zheng2025,
author = {Zheng, Yuan-Liang and Yuan, Yu-Ping and Liang, Xiao-Yong and Liao, Hong-Li},
title = {Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumours without myasthenia gravis: a prospective, single-arm clinical trial},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf122}
}
EUVIMED